Metabolic research
SLU-PP-332
Lyophilized metabolic research compound
SLU-PP-332 is an ERR-pathway research compound studied in exercise-mimetic and metabolic adaptation literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesNur für Laborforschungszwecke. Nicht für den menschlichen oder veterinärmedizinischen Gebrauch bestimmt. Nicht zur Diagnose, Behandlung, Heilung, Linderung oder Vorbeugung von Krankheiten bestimmt.
Verschlossen, kalt, trocken und vor Hitzeschwankungen geschützt aufbewahren. Bestätigen Sie die produktspezifische Lagerung bei der Ankunft.
Verpackt für Transportstabilität mit Bestellunterstützung für Routen bei warmem Wetter.
Batch-linked certificate support is available through the documentation desk.
Forschungskontext
SLU-PP-332 Forschungsprofil
SLU-PP-332 is a small-molecule research compound associated with estrogen-related receptor signaling rather than a peptide hormone pathway. Preclinical studies use it to investigate oxidative metabolism, mitochondrial gene programs, skeletal-muscle adaptation, energy expenditure, and exercise-mimetic phenotypes. The ERR family helps regulate transcriptional networks involved in cellular energy use, so studies often measure gene expression, mitochondrial markers, endurance-related endpoints, and tissue-specific metabolic changes. This compound is best suited to mechanistic cell and animal research that specifically requires an ERR-pathway agonist. The published evidence is preclinical, and experimental findings do not establish human safety, effectiveness, or an appropriate personal-use context.
Molecular class
Synthetic estrogen-related receptor agonist
Sequence / composition
A synthetic small molecule, not a peptide; its chemical scaffold is used to probe ERR transcriptional programs.
Research design note
Research should separate direct ERR engagement from downstream mitochondrial and metabolic transcriptional responses.
Vorgeschlagener Mechanismus
A synthetic agonist reported to activate estrogen-related receptors, especially ERRalpha, ERRbeta, and ERRgamma. ERR activation regulates transcriptional programs involved in mitochondrial biogenesis, oxidative phosphorylation, fatty-acid oxidation, and oxidative muscle-fiber identity.
In Studien berichtete Effekte
- Cell studies reported induction of ERR-regulated oxidative and mitochondrial gene programs.
- Mouse studies reported increased oxidative muscle characteristics, endurance, energy expenditure, and resistance to diet-related metabolic changes.
- The compound is a small molecule rather than a peptide, and no established human efficacy or safety profile exists.
Häufige Forschungsendpunkte
ERR transcriptional activity, mitochondrial genes, oxygen consumption, fatty-acid oxidation, muscle-fiber type, exercise capacity, energy expenditure, glucose tolerance, and body composition.
Evidenz und Grenzen
Evidence is limited to mechanistic and animal research. Human effects, pharmacokinetics, and safety remain unestablished.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.